VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > How much could be a buyout?

<< Previous

Bullboard Posts

Next >>

Comment by chry200030on Dec 17, 2021 12:55pm

148 Views

Post# 34241180

RE:RE:RE:How much could be a buyout?

Anything less than $10 a share would be disappointing. This should be worth between $30 - $50 per shares, so if we get a buyout for $15 - $25 per share, the buyer would double his money.
Patience required.

<< Previous

Bullboard Posts

Next >>

Ur-Energy revises uranium production guidance for 2024